AAAAAA
Results: 1-25/31
Authors:
Kroger, LA
DeNardo, GL
Gumerlock, PH
Xiong, CY
Winthrop, MD
Shi, XB
Mack, PC
Leshchinsky, T
DeNardo, SJ
Citation: La. Kroger et al., Apoptosis-related gene and protein expression in human lymphoma xenografts(Raji) after low dose rate radiation using Cu-67-2IT-BAT-Lym-1 radioimmunotherapy, CANC BIO R, 16(3), 2001, pp. 213-225
Authors:
O'Donnell, RT
DeNardo, SJ
Yuan, A
Shen, S
Richman, CM
Lara, PN
Griffith, IJ
Goldstein, DS
Kukis, DL
Martinez, GS
Mirick, GR
DeNardo, GL
Meyers, FJ
Citation: Rt. O'Donnell et al., Radioimmunotherapy with In-111/Y-90-2IT-BAD-m170 for metastatic prostate cancer, CLIN CANC R, 7(6), 2001, pp. 1561-1568
Authors:
Burke, PA
DeNardo, SJ
Citation: Pa. Burke et Sj. Denardo, Antiangiogenic agents and their promising potential in combined therapy, CR R ONC H, 39(1-2), 2001, pp. 155-171
Authors:
DeNardo, GL
Juweid, ME
White, CA
Wiseman, GA
DeNardo, SJ
Citation: Gl. Denardo et al., Role of radiation dosimetry in radioimmunotherapy planning and treatment dosing, CR R ONC H, 39(1-2), 2001, pp. 203-218
Authors:
DeNardo, GL
DeNardo, SJ
Kukis, DL
O'Donnell, RT
Shen, S
Mirick, GR
Meares, CF
Citation: Gl. Denardo et al., Metabolite production in patients with lymphoma after radiometal-labeled antibody administration, J NUCL MED, 42(9), 2001, pp. 1324-1333
Authors:
DeNardo, GL
DeNardo, SJ
Wessels, BW
Kukis, DL
Miyao, N
Yuan, AN
Citation: Gl. Denardo et al., I-131-Lym-1 in mice implanted with human Burkitt's lymphoma (Raji) tumors:Loss of tumor specificity due to radiolysis, CANC BIO R, 15(6), 2000, pp. 547-560
Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy
Authors:
DeNardo, SJ
Burke, PA
Leigh, BR
O'Donnell, RT
Miers, LA
Kroger, LA
Goodman, SL
Matzku, S
Jonczyk, A
Lamborn, KR
DeNardo, GL
Citation: Sj. Denardo et al., Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy, CANC BIO R, 15(1), 2000, pp. 71-79
Authors:
O'Donnell, RT
DeNardo, SJ
DeNardo, GL
Miers, L
Lamborn, KR
Kukis, DL
Meyers, FJ
Citation: Rt. O'Donnell et al., Efficacy and toxicity of radioimmunotherapy with Y-90-DOTA-Peptide-ChL6 for PC3-tumored mice, PROSTATE, 44(3), 2000, pp. 187-192
Authors:
DeNardo, GL
O'Donnell, RT
Shen, S
Kroger, LA
Yuan, AN
Meares, CF
Kukis, DL
DeNardo, SJ
Citation: Gl. Denardo et al., Radiation dosimetry for Y-90-2IT-BAD-Lym-1 extrapolated from pharmacokinetics using In-111-2IT-BAD-Lym-1 in patients with non-Hodgkin's lymphoma, J NUCL MED, 41(5), 2000, pp. 952-958
Authors:
DeNardo, SJ
Citation: Sj. Denardo, Tumor-targeted radionuclide therapy: Trial design driven by patient dosimetry, J NUCL MED, 41(1), 2000, pp. 104-106
Authors:
Kukis, DL
DeNardo, SJ
Mills, SL
Shen, S
O'Donnell, RT
DeNardo, GL
Citation: Dl. Kukis et al., Stability of monoclonal antibodies, Lym-1 and ChL6, and 2IT-BAD-Lym-1 immunoconjugate with ultra freezer storage, CANC BIO R, 14(5), 1999, pp. 363-369
Authors:
Macey, DJ
DeNardo, GL
DeNardo, SJ
Citation: Dj. Macey et al., Planar gamma camera quantitation of I-123, (99)mTc or In-111 in the liver and spleen of an abdominal phantom, CANC BIO R, 14(4), 1999, pp. 299-306
Authors:
Leigh, BR
Burke, PA
Hong, AM
O'Donnell, RT
Howell, LP
Miers, LA
DeNardo, GL
DeNardo, SJ
Citation: Br. Leigh et al., Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy, CANC BIO R, 14(2), 1999, pp. 113-119
Authors:
Shi, XB
Gumerlock, PH
Kroger, L
DeNardo, GL
DeNardo, SJ
Citation: Xb. Shi et al., Efficient recombination of Lym-1 scFv gene using multiple doubly-restricted DNA fragments, CANC BIO R, 14(2), 1999, pp. 139-143
Authors:
DeNardo, GL
Kukis, DL
Shen, S
DeNardo, DA
Meares, CF
DeNardo, SJ
Citation: Gl. Denardo et al., Cu-67- versus I-131-labeled Lym-1 antibody: Comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma, CLIN CANC R, 5(3), 1999, pp. 533-541
Authors:
Kroger, LA
DeNardo, SJ
DeNardo, GL
Xiong, CY
Winthrop, MD
Gumerlock, PH
Citation: La. Kroger et al., Effect of Cu-67-2IT-BAT-Lym-1 therapy on BCL-2 gene and protein expressionin a lymphoma mouse model, CLIN CANC R, 5(10), 1999, pp. 3010S-3014S
Authors:
Winthrop, MD
DeNardo, SJ
DeNardo, GL
Citation: Md. Winthrop et al., Development of a hyperimmune Anti-MUC-1 single chain antibody fragments phage display library for targeting breast cancer, CLIN CANC R, 5(10), 1999, pp. 3088S-3094S
Authors:
DeNardo, SJ
DeNardo, GL
DeNardo, DG
Xiong, CY
Shi, XB
Winthrop, MD
Kroger, LA
Carter, P
Citation: Sj. Denardo et al., Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics, CLIN CANC R, 5(10), 1999, pp. 3213S-3218S
Authors:
DeNardo, GL
O'Donnell, RT
Kroger, LA
Richman, CM
Goldstein, DS
Shen, S
DeNardo, SJ
Citation: Gl. Denardo et al., Strategies for developing effective radioimmunotherapy for solid tumors, CLIN CANC R, 5(10), 1999, pp. 3219S-3223S
Authors:
Richman, CM
DeNardo, SJ
O'Donnell, RT
Goldstein, DS
Shen, S
Kukis, DL
Kroger, LA
Yuan, A
Boniface, GR
Griffith, IJ
DeNardo, GL
Citation: Cm. Richman et al., Dosimetry-based therapy in metastatic breast cancer patients using Y-90 monoclonal antibody 170H.82 with autologous stem cell support and cyclosporina, CLIN CANC R, 5(10), 1999, pp. 3243S-3248S
Authors:
O'Donnell, RT
DeNardo, GL
Kukis, DL
Lamborn, KR
Shen, S
Yuan, AN
Goldstein, DS
Mirick, GR
DeNardo, SJ
Citation: Rt. O'Donnell et al., (67)Copper-2-iminothiolane-6-[p-(bromoacetamido)benzyl]-TETA Lym-1 for radioimmunotherapy of non-Hodgkin's lymphoma, CLIN CANC R, 5(10), 1999, pp. 3330S-3336S
Authors:
Mirick, GR
O'Donnell, RT
DeNardo, SJ
Shen, S
Meares, CF
DeNardo, GL
Citation: Gr. Mirick et al., Transfer of copper from a chelated Cu-67-antibody conjugate to ceruloplasmin in lymphoma patients, NUCL MED BI, 26(7), 1999, pp. 841-845
Authors:
DeNardo, SJ
Kroger, LA
DeNardo, GL
Citation: Sj. Denardo et al., A new era for radiolabeled antibodies in cancer?, CURR OP IM, 11(5), 1999, pp. 563-569
Authors:
DeNardo, GL
O'Donnell, RT
Rose, LM
Mirick, GR
Kroger, LA
DeNardo, SJ
Citation: Gl. Denardo et al., Milestones in the development of Lym-1 therapy, HYBRIDOMA, 18(1), 1999, pp. 1-11
Authors:
DeNardo, SJ
DeNardo, GL
Brush, J
Carter, P
Citation: Sj. Denardo et al., Phage library-derived human anti-TETA and anti-DOTA ScFv for pretargeting RIT, HYBRIDOMA, 18(1), 1999, pp. 13-21